Replies to post #214045 on NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Right, except they were recurrent GBM and it doubled expected survival (which admittedly is pretty low to begin with).

All the standard caveats apply - small N, unblinded, etc...

The excitement is seeing any signs of efficacy in rGBM. Now to figure out how to maximize it, reduce AEs and combine it with other treatments like DCVax.